Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease
Background. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive def...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2016/1012847 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832551310343274496 |
---|---|
author | Emily J. Henderson Howard Chu Daisy M. Gaunt Alan L. Whone Yoav Ben-Shlomo Veronica Lyell |
author_facet | Emily J. Henderson Howard Chu Daisy M. Gaunt Alan L. Whone Yoav Ben-Shlomo Veronica Lyell |
author_sort | Emily J. Henderson |
collection | DOAJ |
description | Background. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD. |
format | Article |
id | doaj-art-37c791f36aba4dff9955fb15a718676b |
institution | Kabale University |
issn | 2090-8083 2042-0080 |
language | English |
publishDate | 2016-01-01 |
publisher | Wiley |
record_format | Article |
series | Parkinson's Disease |
spelling | doaj-art-37c791f36aba4dff9955fb15a718676b2025-02-03T06:01:43ZengWileyParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/10128471012847Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s DiseaseEmily J. Henderson0Howard Chu1Daisy M. Gaunt2Alan L. Whone3Yoav Ben-Shlomo4Veronica Lyell5School of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKTaunton and Somerset NHS Foundation Trust, Musgrove Park Hospital, Parkfield Drive, Taunton, Somerset TA1 5DA, UKBristol Randomised Trials Collaboration, School of Social and Community Medicine, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKMovement Disorders Group, Bristol Brain Centre, Southmead Hospital, Bristol BS10 5NB, UKSchool of Social and Community Medicine, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol BS8 2PS, UKRoyal United Hospital NHS Foundation Trust, Combe Park, Bath BA1 3NG, UKBackground. MoCA is widely used in Parkinson’s disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitive deficits on MoCA testing, (b) equivalent MoCA and TYM scores, and (c) interrater reliability in TYM testing. Methods. We assessed the discriminant ability of TYM and the equivalence between TYM and MoCA scores and measured the interrater reliability between three raters. Results. Of the 135 subjects that completed both tests, 55% had cognitive impairment according to MoCA. A MoCA score of 25 was equivalent to a TYM score of 43-44. The area under the receiver operator characteristic (ROC) curve for TYM to differentiate between PD-normal and PD-cognitive impairment was 0.82 (95% CI 0.75 to 0.89). The optimal cutoff to distinguish PD-cognitive impairment from PD-normal was ≤45 (sensitivity 90.5%, specificity 59%) thereby correctly classifying 76.3% of patients with PD-cognitive impairment. Interrater agreement was high (0.97) and TYM was completed in under 7 minutes (interquartile range 5.33 to 8.52 minutes). Conclusions. The TYM test is a useful and less resource intensive screening test for cognitive deficits in PD.http://dx.doi.org/10.1155/2016/1012847 |
spellingShingle | Emily J. Henderson Howard Chu Daisy M. Gaunt Alan L. Whone Yoav Ben-Shlomo Veronica Lyell Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease Parkinson's Disease |
title | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease |
title_full | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease |
title_fullStr | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease |
title_full_unstemmed | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease |
title_short | Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease |
title_sort | comparison of test your memory and montreal cognitive assessment measures in parkinson s disease |
url | http://dx.doi.org/10.1155/2016/1012847 |
work_keys_str_mv | AT emilyjhenderson comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease AT howardchu comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease AT daisymgaunt comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease AT alanlwhone comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease AT yoavbenshlomo comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease AT veronicalyell comparisonoftestyourmemoryandmontrealcognitiveassessmentmeasuresinparkinsonsdisease |